secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001411690-25-000005
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics stockholders approve reverse stock split (1:25-1:75) and warrant share issuance
--------------------------------------------------------------------------------

- At Jan 15 special meeting, stockholders approved issuance of up to 19,762,226 shares upon exercise of Series C/D warrants.
- Proposal 2 approved reverse stock split at ratio between 1-for-25 and 1-for-75, with exact ratio to be set by Board.
- Approvals required for Nasdaq listing compliance and to maintain stock price above minimum bid.
- Votes: Proposal 1 – 7.1M for, 3.3M against, 6.7M abstain, 25.3M broker non-votes.
- Votes: Proposal 2 – 29.0M for, 12.8M against, 0.6M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/0001411690-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/bngo-20250115.htm
  HTML page:      https://secwatch.observer/filing/0001411690-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer